| 发明名称 |
Treatment of atherosclerotic disorders |
| 摘要 |
The present invention relates to the identification of lipid oxidizing abzymes as a key pathogenic factor in atherosclerotic disorders. Methods and means for the reduction of abzyme mediated lipid oxidation in the vascular system are provided as therapeutic approaches for the treatment of atherosclerotic disorders. Methods are provide for determining the efficacy of treatment.
|
| 申请公布号 |
US7419657(B2) |
申请公布日期 |
2008.09.02 |
| 申请号 |
US20020225460 |
申请日期 |
2002.08.22 |
| 申请人 |
CAMBRIDGE THERANOSTICS LTD. |
发明人 |
PETYAEV IVAN |
| 分类号 |
A61K31/74;A61K31/047;A61K31/132;A61K31/145;A61K31/16;A61K31/166;A61K31/185;A61K31/195;A61K31/198;A61K31/222;A61K31/341;A61K31/351;A61K31/352;A61K31/355;A61K31/4025;A61K31/409;A61K31/4709;A61K31/5383;A61K31/665;A61K31/7048;A61K35/66;A61K39/118;A61P9/10;C07G11/00;C07H17/08;C07K16/00;C07K16/18;C12N9/00;C12Q1/25;C12Q1/28;G01N33/53;G01N33/561;G01N33/569;G01N33/68;G01N33/92 |
主分类号 |
A61K31/74 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
